BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 27, 2017
View Archived Issues
Neon and Apexigen enter clinical trial collaboration to test NEO-PV-01 with APX-005M in melanoma
Read More
Amgen profiles product and pipeline progress of second quarter 2017
Read More
FDA issues complete response letter for Ryanodex
Read More
MK-8591 shows promise as a novel HIV prophylaxis drug in preclinical and early clinical setting
Read More
AstraZeneca and Merck & Co. collaborate on Lynparza
Read More
Bavarian Nordic and Janssen collaborate on vaccine regimens for HBV and HIV
Read More
STAT6 downregulation in glioblastoma allows cancer cell survival
Read More
Emergent BioSolutions signs Zika licensing agreement with Valneva
Read More
European Commission approves Orencia for psoriatic arthritis
Read More
Compugen and Bayer update collaboration agreement to focus on CGEN-15001T program
Read More
Vosevi now available in U.S.
Read More
FDA grants orphan drug designation to delpazolid for the treatment of tuberculosis
Read More
BioCardia completes roll-in cohort in CardiAMP heart failure trial
Read More
Barbiturate/thiobarbiturate derivatives show promise for hair growth
Read More
PFS endpoint not met in MYSTIC NSCLC trial of Imfinzi plus tremelimumab
Read More
Chondrial's CTI-1601 receives U.S. orphan status for Friedreich's ataxia
Read More
European approval for Faslodex as first-line therapy for advanced postmenopausal breast cancer
Read More
PellePharm's patidegib named orphan drug for Gorlin syndrome
Read More
Phase III FLAURA trial shows PFS benefit with Tagrisso in first-line EGFRm-positive NSCLC
Read More
FDA approves Fycompa as monotherapy for partial-onset seizures
Read More
AbbVie initiates phase I study of ABBV-176 in advanced solid tumors likely to express PRLR
Read More
Novartis studies LML-134 for proof of concept in shift work disorder
Read More
UHRF1 promotes methylation-driven repression of latent HIV-1
Read More
Aelix conducts phase I trial of DNA.HTI and MVA.HTI in HIV-1-positive patients
Read More
